Evidence map›Paper›PMID 31102748›Full record

ArticleBiophysical chemistry2019

Quantifying length-dependent DNA end-binding by nucleoproteins.

Tam Vo, Amanda V Albrecht, W David Wilson, Gregory M K Poon

Abstract read
In one paragraph

Article in Biophysical chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tam VoDepartment of Chemistry, Georgia State University, Atlanta, GA 30303, United States of America.
Amanda V AlbrechtDepartment of Chemistry, Georgia State University, Atlanta, GA 30303, United States of America.
W David WilsonDepartment of Chemistry, Georgia State University, Atlanta, GA 30303, United States of America; Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, GA 30303, United States of America. Electronic address: wdw@gsu.edu.
Gregory M K PoonDepartment of Chemistry, Georgia State University, Atlanta, GA 30303, United States of America; Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, GA 30303, United States of America. Electronic address: gpoon@gsu.edu.

Funding

Molecular Design for Specific Recognition of Functional DNA SequencesR01GM111749 · NIGMS · GEORGIA STATE UNIVERSITY · PI WILSON, W DAVID · 2014 to 2021
$2.5M
NIGMS NIH HHS R01 GM111749
6 · The paper itself

Abstract

The ends of nucleic acids oligomers alter the statistics of interior nonspecific ligand binding and act as binding sites with altered properties. While the former aspect of "end effects" has received much theoretical attention in the literature, the physical nature of end-binding, and hence its potential impact on a wide range of studies with oligomers, remains poorly known. Here, we report for the first time end-binding to DNA using a model helix-turn-helix motif, the DNA-binding domain of ETV6, as a function of DNA sequence length. Spectral analysis of ETV6 intrinsic tryptophan fluorescence by singular value decomposition showed that end-binding to nonspecific fragments was negligible at >0.2 kbp and accumulated to 8% of total binding to 23-bp oligomers. The affinity for end-binding was insensitive to salt but tracked the affinity of interior binding, suggesting translocation from interior sites rather than free solution as its mechanism. As the presence of a cognate site in the 23-bp oligomer suppressed end-binding, neglect of end-binding to the short cognate DNA does not introduce significant error. However, the same applies to nonspecific DNA only if longer fragments (>0.2 kbp) are used.

Indexed as

Binding SitesDNAModels, MolecularNucleoproteinsDNANucleoproteins

Identifiers

PMID31102748
PMCPMC6752047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.